Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma-Reference-Cited by-同舟云学术

Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma

Published:2006-04-28 Issue:11 Volume:106 Page:2363-2368
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tsukamoto Tetsuro,Yonese Junji,Ohkubo Yuhei,Fukui Iwao

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference17 articles.

1. A prospective randomized trial comparing M-VAC and CISCA chemotherapy for patients with metastatic urothelial tumor;Logothetis;J Clin Oncol.,1990

2. Long-term follow-up of a Phase I/II intergroup study of cisplatin alone or in combination with methotrexate, vinblastin, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Saxman;J Clin Oncol.,1997

3. Combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin for metastatic urothelial cancer;Fukui;Cancer Chemother Pharmacol.,2001

4. Weekly gemcitabine in advanced bladder cancer: a preliminary report from Phase I study;Pollera;Ann Oncol.,1994

5. Gemcitabine activity (objective responses and symptom improvement) in resistant Stage IV bladder cancer [abstract];DeLena;Proc Am Soc Clin Oncol.,1996

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Study of Second-line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma;Anticancer Research;2020-03

2. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery;International Journal of Clinical Oncology;2015-05-08

3. Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma;Urologic Oncology: Seminars and Original Investigations;2014-01

4. Harnblasenkarzinom;Uroonkologie;2014

5. Denosumab: a new option in the treatment of bone metastases from urological cancers;OncoTargets and Therapy;2012-09